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In many biomedical studies where the event of interest is recurrent (e.g., hospital
admission), marks are observed upon the occurrence of each event (e.g., medical costs,
length of stay). In Chapter II, we propose novel methods which contrast group-specific
cumulative means, influenced by the recurrent event rate and survival probability.
Our proposed methods utilize a form of hierarchical modeling: a proportional haz-
ards model for the terminating event; a proportional rates model for the conditional
recurrent event rate given survival; and a generalized estimating equations approach
for the marks, given an event has occurred. Group-specific cumulative means are
estimated (as processes over time) by averaging fitted values from the afore-listed
models, with the averaging being with respect to the marginal covariate distribution.
Large sample properties are derived, while simulation studies are conducted to assess
finite sample properties. We apply the proposed methods to data obtained from the
CANADA-USA Peritoneal Dialysis Study (CANUSA).
Typically in observational studies, it is necessary to account for measured and un-
measured heterogeneity across study subjects. This is often accomplished through
model covariates (for measured factors) and frailty variates (to account for unmea-
sured predictors). In Chapter III, we investigate a frequently occurring data structure
where the event of interest is recurrent (e.g., hospital admission), marks are observed
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upon the occurrence of each event (e.g., length of stay) and the recurrent event pro-
cess may be permanently stopped by a terminating event (e.g., death). Similar to
Chapter II, the methods proposed in Chapter III model the terminating event haz-
ard, conditional recurrent event rate given survival and the mark process. However,
in Chapter III all such models are fully parametric, and estimation is carried out
simultaneously. Most importantly, residual correlation across the terminating event,
recurrent event and mark process is captured by a frailty variate, assumed to follow
a Normal distribution. Maximum likelihood based estimation is carried out via a
Gaussian Quadrature technique for integration. Through simulation, the methods
are shown to work well for practical sample sizes. In contrast, significant biases are
detected when estimation is based on methods which fail to account for residual cor-
relation among the event, death and mark processes, especially when heterogeneity
is large within the population.
In Chapter IV, we develop inverse weighting methods to contrast group-specific
cumulative means. Both the underlying data structure and the target estimands are
the same as those from Chapter II. However, for the methods proposed in Chapter
IV, we avoid constructing semi-parametric or parametric models for each process to
achieve consistent estimates. We further take into account of treatment imbalance and
unobserved censoring times by combining Inverse Probability of Treatment Weight-
ing (IPTW) and Inverse Probability of Censoring Weighting (IPCW). Efficiency is






In many biomedical studies, subjects may experience the event of interest multiple
times. Examples include repeated hospital admissions, epileptic seizures, repeated
use of illegal drugs, and others. Although chief interest often lies in modeling the
recurrent event process, often investigators are also interested in an outcome measure
associated with each recurrent event; for example, the medical cost incurred during
each hospitalization, or the length of treatment during each hospital visit. Such
outcome measures are defined as marks, and measure quantitative or qualitative
aspects of each event occurrence. The marks may also be influenced by either internal
or external covariates in the study. In the setting where the study population is
heterogeneous, it is often of interest to know how subjects from different demographic
groups exhibit certain characteristics over the study period, or how subjects from
different populations respond to different treatments over the course of follow-up. One
also needs to acknowledge the fact that the recurrent event process can be terminated
permanently by a terminating event (e.g., death). Since this type of data structure
is very common in biomedical studies, it is of much interest to establish accurate
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methods to appropriately model the marked recurrent event process in the presence
of a terminating event, while accounting for group-specific risk profile difference.
Although there is a rich body of work based on the recurrent/terminal event set-
ting (e.g., Cook and Lawless, 1997; Li and Lagakos, 1997; Ghosh and Lin, 2000,
2002; Huang and Wang, 2004; Liu, Wolfe, and Huang, 2004; Ye, Kalbfleisch, and
Schaubel, 2007), very few methods have been proposed to deal with a marked recur-
rent process which is subject to a terminating event. Ghosh and Lin (2000, 2002)
proposed models for the marginal mean number of events, while Cook and Lawless
(1997) developed models for the conditional recurrent event rate given survival. A
latent variable (frailty) was introduced by Liu et al. (2004) and Ye et al. (2007),
with the recurrent and terminating events assumed to be independent conditional
on the frailty. In comparing group-specific cumulative means, it is often beneficial
to understand the component processes; in particular, the relationship between the
covariates and the terminating event process, the recurrent event process and the
marks associated with each recurrent event. For example, a group’s higher medical
costs might be due to their longer survival, higher hospitalization rate or greater cost
per hospital admission. Interesting group-specific differences with respect to any of
these processes could go undetected if one focuses only on the overall mean.
We propose semiparametric methods that compare group-specific means which
are viewed as processes over time. The proposed methods assume a proportional haz-
ards model for the terminating event; a proportional rates model for the conditional
recurrent event process given survival; and a generalized estimating equations model
(Liang and Zeger, 1986) for the marks given the occurrence of recurrence event. Our
estimator combines the fitted values from the above-listed models by computing the
estimated cumulative mean for each subject, then averaging over all subjects. The
covariate adjustments are allowed to vary for the terminating event process, recurrent
event process and model for marks and for different groups. The baseline hazard for
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the terminating event model and baseline rate for the recurrent event model are also
allowed to be group specific. If any of the component models are of interest, different
modeling strategies could be adopted.
The motivating example for our method is the Canada-USA (CANUSA) Peri-
toneal Dialysis Study, where interest lies in comparing group-specific means between
American and Canadian peritoneal dialysis (PD) patients. The CANUSA study was a
prospective cohort study of patients commencing continuous peritoneal dialysis in 14
centers in Canada and the United States. Between September 1, 1990 and December
31, 1992, a total of 679 patients were enrolled. There were 90 deaths, 130 trans-
plants and 1,340 hospitalizations. Patient’s length of each hospital visit was recorded
and the number of hospitalizations varies between patients. Patients may experience
death during the course of the follow up period. Hence, a patient’s hospitalization
experience is terminated by death. Besides knowing a patient’s survival time (subject
to right censoring) and hospitalization information, we also record factors that might
influence the length of stay (e.g., serum albumin, normalized protein catabolic rate,
subjective global assessment, percent lean body mass, Kt/V, creatinine clearance
rate, country, gender, race).
In many studies, investigators are interested in estimating medical costs associ-
ated with each hospitalization. In the above example, the length of stay during each
hospitalization can be treated as the mark. Length of stay could also be used as a
surrogate for costs. In fact, our proposed method provides an important framework
for analyzing cost data which is rarely discussed in the cost analysis literature. In
terms of cost analysis, mean cost, cumulative cost, lifetime cost or restricted lifetime
cost are of interest. Depending on the setting and objective of the study, nonpara-
metric, marginal, conditional, or joint cost models have been developed (e.g., Lin,
2000; Huang, 2002, 2009; Liu, Conaway, Knaus and Bergin, 2008; Cai, Zeng, and
Pan, 2010). Lin (2000) developed a proportional means regression model for cumu-
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lative medical costs. The proposed inference procedures were semi-parametric and
the method targets “study-duration” medical cost. Since study duration is a some-
what artificial time limit, and since the covariates might impact survival as well, the
interpretation of such results may be inappropriate in terms of inference regarding
true lifetime medical cost. Huang (2002) developed calibration regression methods
to model lifetime medical cost and survival time jointly. The method postulates lin-
ear covariate effects on both lifetime medical cost and survival time, which can be
measured on certain transformed cost and time scales, respectively. Liu et al. (2008)
developed a four-part random effects model to analyze correlated medical cost data.
The model of Liu et al. (2008) targets longitudinal costs, (e.g., the cost accumulation
process), instead of total costs. The model also takes account of both the mean struc-
ture and inter-temporal correlation among longitudinal medical costs. In addition,
the model of Liu et al. (2008) takes into consideration the presence of zero costs. In
recent work of Cai, Zeng, and Pan (2010), costs are treated as marks, with each mark
being associated with the occurrence of each recurrent event. Therefore, the method
of Cai et al. (2010) could be classified as a conditional model for cost data.
We structure the remainder of the chapter as follows. In Section 2.2, we introduce
the proposed model, followed by the estimation method. Asymptotic properties are
listed in Section 2.3, with proofs of the theorems given in the Appendix. Simulation
studies are reported in Section 2.4. An application of our approach is given in Section
2.5. In Section 2.6, we provide discussion and explore some future research areas.
2.2 Proposed Models and Estimating Methods
2.2.1 Notation and setup
We first establish the required notation. Let Di denote the time of the termi-
nating event for subject i, while Ci is the censoring time for subject i. We let
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Xi = min(Ci, Di) and let Yi(t) = I(Xi ≥ t) be the at-risk indicator. We let the
true terminating event process be represented by N∗Di (t) and we let N
∗R
i (t) equal the
total number of recurrent events for subject i up to time t. The observed terminat-
ing event process and recurrent event process are NDi (t) = I(Di ≤ t,Di < Ci) and
NRi (t) = N
∗R
i (t ∧ Xi), respectively. Notice that recurrent events do not occur after
death. We define Gi(t) as the mark for subject i at time t. It is assumed that marks
only occur at time of a recurrent event. In addition, subjects are divided into groups
(e.g., by treatment type, gender, diagnosis) and Ai is used to denote group for sub-
ject i. For ease of presentation, we consider the case where Ai is binary (Ai = 0, 1),
although the proposed methods can accommodate more than two groups. We then
set up the group indicator Aij = I(Ai = j). Each subject is characterized by a vector
of covariates, Zi.







with mean µij(t), defined as
µij(t) = E[B
∗
i (t)|Zi, Ai = j].
That is, µij(t) represents the mean of B
∗
i (t) for a subject with covariate Zi, under the
hypothetical scenario where subject i is a member of group j. We wish to estimate














where Sij(u) = P (Di > u|Zi, Ai = j), gij(u) = E(Gi(u)|dN∗Ri (u) = 1, Zi, Ai = j) and
dRij(u) = E(dN
∗R
i (u)|Zi, Di > u,Ai = j).
To contrast group-specific means, we first define µj(t) as the cumulative mean for
group j averaging across the marginal distribution of Zi. That is, µj(t) = E[µij(t)] =
E[E[B∗i (t)|Ai = j, Zi]] for j = 0, 1, where the outer expectation is taken with re-
spect to the marginal distribution of Zi. The quantities µ0(t) and µ1(t) are averaged
with respect to the same covariate distribution. The difference in cumulative means
between the two groups can be expressed as
δ(t) = µ1(t)− µ0(t). (2.2)
The goal here is to estimate δ(t), methods for which are proposed in the next
subsection.
2.2.2 Estimation
We estimate µj(t) through µij(t), and semiparametric models are assumed for each
process in (3.1). The terminating event hazard is assumed to follow a proportional
hazards model,




where βD is a parameter vector, Λ0j(t) =
∫ t
0
λ0j(s)ds is the group-specific cumulative
baseline hazard, and ZiD is a covariate vector comprised of appropriate elements of
Zi or functions thereof. Model (3.3) implies group-specific baselines and a regression
parameter that is shared across groups. Note that group-specific regression coefficients
are obtained through inclusion of group × covariate interactions. The estimator of








Aij{ZiD − Z̄j(t; βD)}dNDi (t), (2.4)
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for k= 0, 1, 2, with Z⊗0iD = 1, Z
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iD. The baseline hazard is
estimated through the Breslow-Aalen method,











Having computed β̂D and Λ̂0j(t, β̂D), subject-specific survival can be estimated for
each group via Ŝij(t) = exp{−Λ̂0j(t; β̂D) exp{β̂
′
DZiD}}.
Next, we assume a proportional rates model for the conditional recurrent event
rate given survival, as






r0j(s)ds is the cumulative baseline rate, ZiR is a covariate vector
derived from elements of Zi, and βR is the regression parameter. The right hand side
of equation (2.6) is the familiar proportional rates model (Lin et al., 2000) applied to
the conditional event rate given survival (e.g., as in Liu et al., 2004; Schaubel and Cai,
2005; Ye at al., 2007). Then βR and R0j(t) can be estimated through a process-based
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ij (s; βR) = 0 (2.8)








limit τ satisfies P (Xi ≥ τ) > 0 and is typically set to max {Xi}. Solving equation








Aij[ZiR − Z̄j(s; βR)]dNRi (s), (2.9)
where S
(k)






RZiR} for k = 0, 1, 2, while R0j(t; βR)
can be estimated by its Breslow-Aalen analog,










We assume the following model for the mark process,
gij(t) ≡ E[Gi(t)|dN∗Ri (t) = 1, Zi, Ai = j] = g(t; βG, ZiG, Ai = j), (2.11)
where ZiG is a covariate vector consisting of elements of Zi and an intecept term, and
βG is the corresponding parameter vector. The function g is a monotonic differentiable
function of t, βG, ZiG and Ai.
In order to avoid distributional assumptions on Gi(t), we estimate model (2.11)
using GEE. We let Gi = [Gi(Ti1), Gi(Ti2), ..., Gi(TiNRi )]
′
= [Gi1, Gi2, ..., GiNRi ]
′
and the
corresponding mean vector given ZiG, Ai and dN
∗R









where Hi is a N
R
i × NRi diagonal matrix with v(gijl) as the lth diagonal element
with l = 1, . . . , NRi . The variance function v is determined by the specific work-
ing probability distribution used for the marks, and φ is a dispersion parameter.
The quantity Ri(α) is the correlation matrix of Gi; for instance, an exchangeable
structure, corr(Gil, Gik) = α, for l 6= k. The working correlation matrix can be
estimated through an iterative fitting process by using the current value of the pa-
rameter vector to compute the appropriate functions of the Pearson residual êijl =














i [Gi − gij]. (2.12)
We can obtain an estimate of βG and Vi by the following iterative algorithm:
1. Compute an initial estimate of βG assuming independence among (Gil, Gik), for
l 6= k
2. Compute the working correlation Ri(α) based on the standard residuals, the
current βG and the assumed structure of Ri(α)

































i (Gi − gij)
]
5. Iterate between steps 2-4 until convergence.

































i −1), p being the number of regression parameters. Note that, under a working
independence assumption, Ri(α) is replaced by the identity matrix. If φ is not known












If the working correlation matrix is misspecified, that is Cov(Gi) 6= Vi, we still get



















































In computing Σ̂, β and α are replaced by their estimated values, while Cov(Gi)
is replaced by [Gi − gij(β̂G)][Gi − gij(β̂G)]′.
Finally, after estimating βD, βR, βG, R0j(t) and Λ0j(t), we can estimate µj(t) by
replacing the true parameters with their estimated counterparts, then averaging over
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The group-specific difference, δ(t), is then estimated by
δ̂(t) = µ̂1(t)− µ̂0(t). (2.15)
In the above estimation of δ(t), we allow βD, βR and βG to be shared among
different groups. In the event that the βD, βR and βG are group-specific, we can
develop similar estimation procedures from the following models:
λij(t) = λ0j(t) exp{β
′
DjZiD} (2.16)
rij(t) = r0j(t) exp{β
′
RjZiR} (2.17)
gij(t) = g(t; βGj, ZiG, Ai = j). (2.18)
2.3 Asymptotic Properties
In this section, we summarize the essential asymptotic behavior of the proposed
estimators by first listing the necessary conditions, for i = 1, . . . , n and j= 0, 1.
(a) {N∗Ri (.), Di, Ci, Zi, Ai, Gi(.)} are independent and identically distributed
(b) E[dN∗Ri (t)|Di > t, Zi, Ai, Ci > t]=E[dN∗Ri (t)|Di > t, Zi, Ai]
(c) E[Gi(t)|dN∗Ri (t) = 1, Zi, Ai, Ci > t] = E[Gi(t)|dN∗Ri (t) = 1, Zi, Ai]
(d) lim
δ→0
Pr{t ≤ Di < t+ δ|Di > t, Zi, Ci > t} = lim
δ→0
Pr{t ≤ Di < t+ δ|Di > t, Zi}







dR0j(t) <∞ and NRi (τ) <∞
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(g) Elements of Zi are bounded almost surely.




ADj (βD) = E
 τ∫
0











− z̄j(t; βR)⊗2}s(0)j (t; βR)dR0j(t)













Zi}], d = 0, 1, 2.
Now, we describe the main asymptotic results from the proposed procedures.
Proofs of the theorems are provided in the Appendix.
Theorem II.1. Under conditions (a) to (h) and models (3.3),(3.6) and (3.11), µ̂j
is a uniformly consistent estimator of µj. That is, µ̂j(t) converges to µj(t) almost
surely for j=0,1 and t ∈ (0, τ ]. In addition, n1/2{µ̂j(t) − µj(t)} converges weakly
to a zero-mean Gaussian process for j=0,1 and t ∈ (0, τ ] with covariance function















{ZiD − z̄j(r; βD)}
′
×dΛ0j(r)gij(u|ZiG)dRij(u|ZiR)]




















































Aij{ZiR − z̄j(t; βR)}dMRi (t; βR)






i [Gi − gij].
The proof of Theorem 1 unfolds through a series of Taylor expansions, several
applications of the Strong Law of Large Numbers (Sen and Singer, 1993) and the
Multivariate Central Limit Theorem (MCLT). A demonstration of tightness completes
the proof of weak convergence using various results from empirical processes (Pollard
1990; van der Vaart and Wellner 1996; Bilias et al. 1997). In the next Theorem, we
describe asymptotic results for δ̂(t).
Theorem II.2. Under conditions (a) to (h) and models (3.3),(3.6) and (3.11), δ̂(t)
is a uniformly consistent estimator of δ(t). That is, δ̂(t) converges to δ(t) almost
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surely for j=0,1 and t∈ (0, τ ]. Further, n1/2{δ̂(t)− δ(t)} converges weakly to a zero-
mean Gaussian process with covariance function σδ(s, t) = E[{ξi1(s)−ξi0(s)}{ξi1(t)−
ξi0(t)}].
It follows from Theorem 1 that n1/2{µ̂1(t)− µ̂0(t)} is asymptotically equivalent to
n−1/2
∑n
i=1{ξi1(t) − ξi0(t)}, a scaled sum of zero-mean Normal variates. For fixed
(s, t), convergence follows from the MCLT. Tightness follows from empirical processes
theory. The covariance σδ(s, t) can be consistently estimated by replacing all limiting
values with their empirical counterparts, then averaging across all subjects for i =
1, . . . , n.
2.4 Simulation Study
The terminating event was generated from λij(t) = λ0j exp{β
′
DZi}, a propor-
tional hazards model where Zi = (Zi1, Zi2, Zi3)
′. The Cox regression parameter was
set to βD = (0.5, 0.3, 0.3)
′, with λ0j=0.03 or 0.06. We let Zi1 ∼ Bernoulli(0.5),
with Zi2 generated through the model P (Zi2 = 1|Zi1)=expit{h1Zi1} and P (Zi3 =
1|Zi1, Zi2)=expit{h2Zi1 + h3Zi2}, where (h1, h2, h3)′ = (1, 1, 1)′ and with expit(h)=
exp{h}[1 + exp{h}]−1. We generated recurrent events from the model rij(t) =
Qir0j exp{β
′
RZi} by generating gap times between successive events as: Ti,k+1 =
Ti,k − Qi log(Ui,k)[r0j exp{β′RZi}]−1 for k = 1, . . . , 50, where each of the Ui,k variates
followed a Unif(0,1) distribution. The frailty, Qi, could be considered an unmeasured
predictor that is shared by all recurrent event times for the same subject. We let
Qi ∼ Gamma(θ) where θ= 0.5 or 0.25 and represents Var(Qi); note that E(Qi) = 1.
We set r0j= 0.25 or 0.20, with the regression parameter set to βR = (0.5, 0.3, 0.3)
′.
The model for the marks was as follows: gi(t) = βG0 +βG1t+βG2Zi1 +βG3Zi2 +βG4Zi3,
with (βG0 , βG1 , βG2 , βG3 , βG4)
′=(1, 1, 1, 1, 1.5)′. In the simulation, a working indepen-




0j exp{βD3Zi3} and truncated at 60, which results in 30% ∼ 40% of cen-
soring for different simulation configurations. The average observed number of re-
current events ranged from 2 to 4 per subject. Cumulative means were estimated at
t = 3, 6, 9, 12, in order to give comparisons for early, middle and late follow up times.
Sample sizes were set at n = 400 and 500 replicates were generated per configuration.
Table 2.1 provides results for the population average cumulative mean estimator
for the various data configurations examined. For all data configurations, the esti-
mated cumulative means are very close to the true values. The average asymptotic
standard errors (ASE) agree well with the empirical standard deviations (ESD) and,
correspondingly, the empirical coverage probabilities (CP) are close to the nominal
value of 0.95.
In Table 2.2, we evaluated the proposed treatment effect estimator, δ̂(t) = µ̂1(t)−
µ̂0(t). The biases at different follow-up times are negligible compared to the true
values. The ASEs also agree well with the ESDs, with the CP being generally quite
close to the nominal value of 0.95.
2.5 Application
We applied our method to the CANUSA study to compare the estimated cumula-
tive mean days hospitalized between U.S. versus Canadian peritoneal dialysis patients.
All patients commencing continuous PD between September 1, 1990 and December 31,
1992 were eligible for the study. Demographic data recorded at enrollment included
age, sex, race, functional status according to the Karnofsky score, underlying renal
disease, insulin-dependent diabetes mellitus (IDDM), and history of cardiovascular
disease (CVD). Estimates of nutritional status included subjective global assessment
(SGA), protein catabolic rate (PCR) and percentage of lean body mass (PCTLBM).
Adequacy of dialysis was estimated by measurement of total weekly Kt/V for urea, to-
tal weekly creatinine clearance (CCr), and serum beta-2-microglobulin(β2M). Death
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served as the terminating event, while the recurrent event was hospitalization. Length
of stay (number of days hospitalized) served as the mark for each hospital visit. Then,
the natural interpretation of cumulative mark would be the total number of days hos-
pitalized, which is our main interest.
A total of n = 679 patients were enrolled in the study. There were many more
males (393) than females (286) enrolled. The mean age was 54, with a range of 18
to 82 years. Follow-up was terminated on December 31, 1993. There were 90 deaths,
and the average number of days hospitalized across all patients was 7.8 days per pa-
tient. Of primary interest was to compare American and Canadian patients. Adjust-
ment covariates included serum albumin (SALB), normalized protein catabolic rate
(NPCR), subjective global assessment (SGA), percent lean body mass (PCTLBM),
age, Karnofsky score and cardiovascular disease (CVD).
We first investigated the impact of each factor on the terminating event (e.g.,
mortality), recurrent event (e.g., hospitalization) and the marks (e.g., number of days
hospitalized) based on the afore-listed covariates adjustment by fitting a proportional
hazards model, a proportional rates model and a GEE model for the mark process,
respectively. Table 2.3 gives the parameter estimates and p-values for the proportional
hazards model, proportional rates model and a GEE linear regression model for the
mark process. In the Canadian group, the only covariate that was significant for the
terminating event model include percent lean body mass. A 1% increase in lean body
mass is associated with 6% decrease in death hazard adjusting for other variables.
In the American group, the covariates that were significant for the terminating event
model include PCTLBM, age, CVD and SALB. For those patients who have a history
of CVD, the mortality hazard is 2.27 times that of patients without CVD, adjusting
for other covariates. A 1g/L increase in serum albumin concentration is associated
with 6% decrease in the death hazard, covariate adjusted. Factors that are significant
predictors of the hospital admission rate for either group include PCTLBM, Karnofsky
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score, SALB and CVD. For the American patients, PCTLBM and age are significant
in the model for marks, in addition to follow-up time. For the Canadian patients, only
follow-up time is significant. Lower percentage of lean body mass, increased age and
early hospitalization are associated with longer length of stay. Overall, percentage
lean body mass and CVD are either significant or borderline significant in either the
terminating event model or the recurrent event model for patients in both countries.
Follow-up time at hospital admission is significant for both countries.
As evident in Figure 2.1, the estimated cumulative mean days hospitalized is
slightly higher for Canadian patients than for American PD patients. This holds for
most of the observed follow-up period, with the difference slightly decreasing with
the increase in follow-up time. In addition, we estimated the difference in cumulative
mean for American and Canadian PD patients at every half year interval and found
that the difference tends to become increasingly non-significant as follow-up time
increases (Table 2.4). Figure 2.2 gives the differences in cumulative mean between
the patients in the two countries, and shows no trend during the first year, then a
mild decreasing trend thereafter as time increases. The estimated cumulative mean
difference stayed slightly above zero within the two year follow-up time window.
2.6 Discussion
We developed semiparametric methods to compare group-specific cumulative means
associated with marked recurrent events in the presence of a terminating event. Our
methods combine a proportional hazards model (Cox, 1972) for the terminating event,
a proportional rates model (Lin et al, 2000) for the conditional recurrent event rate
given survival and a GEE model for the marks. We estimated the terminating event
hazard, recurrent event rate given survival and the marks given each recurrent event
separately, integrating to get the estimated group-specific means. In our modeling,
the parameters of interest are estimated separately. This is different from methods
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that involve joint estimation or conditional estimation of the parameters of inter-
est. In addition, we do not assume the covariates are necessarily shared by different
models. The group-specific means are each averaging over the marginal covariate
distribution, such that covariate imbalances are factored out.
Schaubel and Zhang (2010) developed a method which targets the same δ(t) of
interest in our work. In the work of Schaubel and Zhang (2010), imbalances in
the group-specific covariate distributions are adjusted through Inverse Probability
of Treatment Weighting. The models of Schaubel and Zhang (2010) require that
the censoring time be conditionally independent of the adjustment covariates, given
group. The consistency of their estimators also requires that the logistic model for
group assignment be correct. These assumptions would not be necessary in our
approach. A potential advantage of Schaubel and Zhang (2010) is that the method
does not require models for µj(t) or its components. That said, our proposed method
does not require a model for µj(t) per se, and the models for the components would
often be of interest to investigators.
In the causal inference literature, our measure could be interpreted as an average
causal effect estimator. Chen and Tsiatis (2001) developed methods in estimating the
average causal treatment difference in restricted mean lifetime. The causal treatment
effect is defined through counterfactual random variables. In our modeling, the causal
issues are not our main focus. Note that the appropriate application of the term causal
depends on other properties of the observed data.
One potentially very useful variation of our methods would be joint modeling
techniques. Cai et al.(2010) developed a semi-parametric proportional means model
for marker data contingent on recurrent events. The authors used a marginal rate
model, while the marks were analyzed through a proportional means model. The
parameters for the marginal rate model and those of the proportional means model are
linked by estimating equations through which the parameters are estimated jointly.
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A terminating event was not considered. Another useful extension of our work would
be incorporating shared latent variables, such that the recurrent event process would
be subject specific and could allow for residual correlation between the terminating
and recurrent event processes.
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Table 2.1: Simulation Results: Performance of Proposed Estimator
λ00, λ01 r00, r01 V (Qi) t % at risk µ1(t) Bias ESD ASE CP
0.03/0.03 0.20/0.25 0.5 3 71% 6.98 0.04 0.77 0.74 0.92
6 53% 16.01 0.10 1.75 1.72 0.95
9 40% 26.12 0.27 2.92 2.95 0.96
12 29% 36.66 0.35 4.31 4.38 0.96
0.03/0.03 0.20/0.25 0.25 3 71% 6.98 0.04 0.56 0.65 0.98
6 53% 16.01 0.18 1.34 1.51 0.97
9 40% 26.12 0.02 2.26 2.59 0.97
12 29% 36.66 0.00 3.34 3.90 0.96
0.03/0.06 0.25/0.25 0.5 3 59% 6.23 0.02 0.66 0.67 0.95
6 40% 12.84 0.02 1.50 1.43 0.93
9 23% 18.98 0.11 2.42 2.28 0.92
12 16% 24.38 0.22 3.31 3.18 0.94
0.03/0.06 0.25/0.25 0.25 3 59% 6.23 0.04 0.57 0.60 0.96
6 40% 12.84 0.04 1.22 1.29 0.95
9 23% 18.98 0.11 1.92 2.07 0.96
12 16% 24.38 0.04 2.64 2.87 0.96
0.06/0.06 0.25/0.20 0.5 3 59% 4.99 0.03 0.57 0.56 0.94
6 40% 10.27 0.13 1.18 1.19 0.95
9 23% 15.19 0.19 1.82 1.87 0.96
12 16% 19.50 0.20 2.47 2.58 0.96
0.06/0.06 0.25/0.20 0.25 3 59% 4.99 0.00 0.45 0.49 0.97
6 40% 10.27 0.05 0.98 1.06 0.95
9 23% 15.19 0.06 1.53 1.67 0.96
12 16% 19.50 0.10 2.09 2.35 0.96
Notes: βD = (0.5, 0.3, 0.3)
′, βR = (0.5, 0.3, 0.3)
′, βG = (1, 1, 1, 1, 1.5)
′. Number of
repetitions: 500. Number of subjects: n = 400.
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Table 2.2: Simulation Results: Treatment effects
λ00, λ01 r00, r01 V (Qi) t % at risk δ(t) Bias ESD ASE CP
0.03/0.03 0.20/0.25 0.5 3 71% 1.40 0.01 0.86 0.80 0.94
6 53% 3.20 0.07 1.88 1.92 0.96
9 40% 5.22 0.14 3.16 3.41 0.96
12 29% 7.33 0.07 4.79 5.20 0.96
0.03/0.03 0.20/0.25 0.25 3 71% 1.40 0.04 0.74 0.76 0.97
6 53% 3.20 0.06 1.62 1.83 0.97
9 40% 5.22 -0.05 2.73 3.23 0.97
12 29% 7.33 -0.25 4.04 4.94 0.98
0.03/0.06 0.25/0.25 0.5 3 59% 0.75 -0.03 0.90 0.87 0.93
6 40% 3.17 -0.07 1.94 2.02 0.95
9 23% 7.14 -0.19 3.30 3.47 0.95
12 16% 12.29 -0.59 4.78 5.15 0.96
0.03/0.06 0.25/0.25 0.25 3 59% 0.75 -0.08 0.82 0.82 0.95
6 40% 3.17 -0.08 1.80 1.93 0.97
9 23% 7.14 -0.16 2.97 3.32 0.97
12 16% 12.29 -0.05 4.35 4.92 0.97
0.06/0.06 0.25/0.20 0.5 3 59% 1.25 -0.03 0.87 0.78 0.91
6 40% 2.57 -0.13 1.74 1.73 0.93
9 23% 3.80 -0.06 2.76 2.84 0.96
12 16% 4.88 0.11 3.83 4.02 0.96
0.06/0.06 0.25/0.20 0.25 3 59% 1.25 0.09 0.74 0.75 0.94
6 40% 2.57 0.16 1.59 1.66 0.96
9 23% 3.80 0.25 2.53 2.71 0.96
12 16% 4.88 0.29 3.52 3.84 0.96
.
Notes: βD = (0.5, 0.3, 0.3)
′, βR = (0.5, 0.3, 0.3)
′, βG = (1, 1, 1, 1, 1.5)
′.Number of
repetitions: 500. Number of Subjects: n = 400
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Table 2.3: Analysis of CANUSA data: Parameter estimates for terminating event
model, recurrent event model and model for marks
λij(t) rij(t) gij(t)
Variable β̂D p exp{β̂D} β̂R p exp{β̂R} β̂G p
CANADA
PCTLBM -0.06 0.03 0.94 -0.02 0.02 0.98 -0.03 0.61
AGE 0.01 0.71 1.01 -0.01 0.33 0.99 0.00 0.98
KARNOF -0.02 0.19 0.98 -0.02 0.01 0.98 -0.13 0.03
CVD 0.84 0.12 2.32 0.56 0.01 1.75 0.44 0.76
SALB 0.01 0.91 1.01 0.00 0.90 1.00 0.10 0.50
NPCR -0.94 0.50 0.39 -0.09 0.83 0.92 1.17 0.68
SGA 0.08 0.62 1.09 -0.02 0.76 0.98 0.58 0.28
TIME - - - - - - -0.30 <0.001
USA
PCTLBM -0.02 0.05 0.98 -0.01 0.16 0.99 -0.08 0.00
AGE 0.02 0.04 1.02 0.00 0.42 1.00 0.07 0.01
KARNOF 0.01 0.15 1.01 0.00 0.29 1.00 0.00 0.90
CVD 0.82 0.00 2.27 0.15 0.14 1.12 1.31 0.11
SALB -0.07 0.01 0.94 -0.02 0.02 0.98 -0.13 0.15
NPCR -0.29 0.55 0.75 0.22 0.25 1.24 1.51 0.37
SGA 0.01 0.93 1.01 -0.01 0.85 0.99 -0.18 0.58
TIME - - - - - - -0.27 <0.001
.
Notes: λij(t): Survival model rij(t): Recurrent event model gij(t): marks model
p: p-value
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Table 2.4: Analysis of CANUSA data: Difference in length of hospital-
ization between American and Canadian patients over time
(Canadian minus American)
Months δ̂(t) ŜE{δ̂(t)} P-value
6 2.79 1.98 0.17
12 4.02 3.23 0.22
18 2.32 3.87 0.56
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The solid line represents American (j = 0) PD patients, and dashed line represents
Canadian (j = 1) PD patients.
Figure 2.1: Analysis of the CANUSA data: Estimated cumulative mean number of




























The solid line represents the estimated cumulative mean difference in days hospitalized
(Canadian minus American). The dashed lines represent the corresponding 95%
confidence intervals.
Figure 2.2: Analysis of the CANUSA data: point estimates and 95% confidence in-
tervals for the estimated cumulative mean difference in days hospitalized




Joint modeling of marked recurrent events in the
presence of a terminating event
3.1 Introduction
In public health and medicine, the event of interest is often recurrent (e.g., re-
peated tumor occurrences, a series of hospitalizations). In recent decades, the study
of such recurrent event process has drawn more and more attention. Often, the re-
current events have certain descriptive characteristics (e.g., size of tumor, or length of
stay in each hospital visit). We refer to such these outcome measures associated with
the recurrent events as “marks”. In a sense, the mark characterizes each recurrent
event. In clinical trials or epidemiologic studies, it is often the case that study sub-
jects may die during the course of follow-up. Accurate analysis of recurrent events in
this type of setting should allow for the fact that a terminating event may occur.
We further acknowledge the fact that both measured and unmeasured hetero-
geneity exists across study subjects, especially in observational studies. To account
for measured heterogeneity, various regression models can be developed by including
important adjustment factors as covariates. On the other hand, unmeasured het-
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erogeneity could be explained via a “frailty” variate, an approach which has gained
increasing popularity in recent decades, especially in the area of survival analysis.
The purpose of a frailty (or random effect) is to represent unobserved heterogeneity
in the model; which is appropriate if there is reason to believe that subjects with
the same covariate value may have unequal risk of death or relapse of a particular
disease. The term frailty was introduced by Vaupel, Manton and Stallard (1979) in
the univariate survival analysis setting and was extended to the multivariate survival
setting by Clayton (1978). In the context of the recurrent/terminal event setting,
various methods have been developed to jointly model the dependence between the
recurrent event and terminal event process using a frailty, e.g., Wang, Qin and Chi-
ang, 2001; Huang and Wang, 2004; Liu, Wolfe and Huang, 2004; Ye, Kalbfleisch and
Schaubel, 2007. By incorporating the frailty, we can potentially allow for residual cor-
relation beyond what can be captured by the adjustment covariates. We investigate
a type of data structure where the subjects may experience a sequence of recurrent
events. These recurrent events are only observable if the study subjects are alive at
each recurrent event occurrence. In other words, the recurrent event process may be
stopped by the terminating event. The marks of these subjects are only observed
if they experience each recurrent event. In Chapter III, interest lies not only in the
individual processes (e.g., recurrent event, terminating event, mark), but also in the
dependence structure among these processes; where the dependence is not only be-
tween the recurrent and terminal event but also between the recurrent/terminal event
and the outcome measure associated with each recurrent event.
We propose joint modeling techniques targeted at the setting where, in addition to
covariate effects, interest also lies in the heterogeneity within the study population, as
well as the shape of the baseline death hazard and recurrent event rate functions. The
proposed methods assume a proportional hazards model for the terminating event; a
proportional rates model for the conditional recurrent event process given survival;
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and a Poisson regression model for the marks given the occurrence of recurrence event.
The baseline hazard is chosen to be piecewise constant in the assumed proportional
hazards model. Similarly, the baseline rate for the recurrent event model is also
assumed to be piecewise constant. Since the marks are generally non-negative, the
Poisson distribution would appear to be a reasonable choice. In addition, we assume
the frailty is at the subject level and applies to all three afore-listed models. The
variance of the frailty variate reflects the degree of residual correlation among the
death, recurrent event and mark process.
The application for our proposed models is the well-known Canada-USA (CANUSA)
Peritoneal Dialysis Study(Canada-USA (CANUSA) Peritoneal Dialysis Study Group,
1996; Churchill, 1998; Ye, Kalbfleisch and Schaubel, 2007). The CANUSA Study
Group (1996) focused on evaluating the relationship of adequacy of dialysis and nu-
tritional status to mortality and morbidity. Churchill (1998) targeted the implication
of adequacy of dialysis on peritoneal dialysis schedule. Ye, Kalbfleisch and Schaubel
(2007) utilized the CANUSA study data to model the relationship between the hospi-
talization rates and failure of peritoneal analysis. One of our interests in this Chapter
is the hospital admission or number of days hospitalized, which has rarely been pre-
sented before. Duration of hospital stay serves as the marks, which are only observed
when a hospital admission occurs. The survival information (e.g., death, censor-
ing) underlies the proportional hazards model and the PD patients’ hospitalization
times serves as the foundation of our recurrent event model, which is interpreted
as being conditional on survival. Some of the clinical and non-clinical factors that
are present in the above models are as follows: serum albumin, normalized protein
catabolic rate, subjective global assessment, percent lean body mass, Kt/V, creati-
nine clearance rate, country, gender and race, Karnofsky score, cardiovascular disease
and underlying cause of renal disease.
We structure the remainder of the chapter as follows. In Section 3.2, we introduce
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the proposed proportional hazards model, proportional rates model and Poisson re-
gression model, followed by the Gaussian quadrature estimation method. We conduct
simulation studies in Section 3.3. In Section 3.4, we illustrate our proposed methods
by applying them to the CANUSA study. In Section 3.5, we conclude this chapter
with some discussion and future research areas.
3.2 Proposed Models and Estimating Methods
3.2.1 Notation and Setup
We first establish the required notation. Let Di denote the time of the terminating
event for subject i, while Ci is the censoring time. The quantity, Xi = min{Di, Ci},
is the observation time. Then, we denote N∗Ri (t) as the total number of recurrent
events for subject i up to time t. In addition to the terminating event, we introduce
Tik, a sequence of recurrent event times for suject i, i = 1, . . . , n; k = 1, . . . , ni. Let
δi = I(Di ≤ Ci) and ∆ik = I(Tik ≤ Xi), indicators for subject i’s terminating event
and recurrent event time, respectively. Last, we introduce the event for the marks.
Notice that recurrent events do not occur after death and marks are only observed
at time of each uncensored recurrent event. Therefore it is implied that there is no
information on the mark process available after the subject is dead or at times when
the subject does not experience a recurrent event. Define Gi(t) as the observed mark
for subject i at time t. Often times, the marks are non-negative (e.g., number of days
hospitalized, cell counts for each diagnosis) and, therefore, we assume Gi(t) ≥ 0. The
covariate vector is denoted by Zi = {ZiD, ZiR, ZiG}, where ZiD, ZiR and ZiG represent
the covariate vectors for the terminating event model, recurrent event model and the
mark model respectively.
Collecting the previously-listed assumptions and conditions, the underlying data
structure and proposed approach can be summarized as follows. The terminating
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event process and the recurrent event process are correlated for the same subject
through a mutual correlation with the covariate, Zi, and also through a common
random effect, wi. The recurrent events only occur while the subject is alive. The
recurrent event and the marks are also correlated for the same subject through the
same random effect, wi. The marks are only observed when the subject experiences
a recurrent event. The marks are non-negative and follow a Poisson distribution. For
both the terminating event hazard and recurrent event rate, the overall shape does
not have to be imposed in advance; although constancy is assumed within pre-defined
sub-intervals of time. If the follow-up time sub-intervals are chosen to be sufficiently
small, one should obtain a fairly close approximation of the true underlying baseline
rate and hazard functions.
3.2.2 Proposed Models
Based on the above assumptions, we establish the following piecewise proportional
hazards model for the terminating event hazard. Let a0 = 0 < a1 < ..... < aK−1 <
aK =∞ be a partition of the follow-up time. The hazard for the ith subject is given
by
dΛi(t) = dΛ(t) exp{β
′
DZiD + wi}, (3.1)
where dΛ(t) =
∑K
k=1 λkI(ak−1 ≤ t < ak) is the baseline hazard function. The likeli-















exp{β ′DZiD + wi}
K∑
k=1
λkI(ak−1 ≤ t < ak)dt
 . (3.2)
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Then, we establish the following proportional rates model for the conditional recurrent
event rate given survival. Let b0 = 0 < b1 < ..... < bQ−1 < bQ = ∞ be another
partition of the follow-up of time axis, noting that it is not required to be the same




i (t)|Di ≥ t, ZiR, wi]
= dR(t) exp{β ′RZiR + wi}, (3.3)
where dR(t) =
∑Q
q=1 rqI(bq−1 ≤ t < bq) is the baseline recurrent event rate. Note
that the recurrent event rate here is a conditional quantity; the conditional event
rate, given survival. This expression resembles that of Ye, Kalbfleisch and Schaubel
(2007) and Pan and Schaubel (2009). The likelihood contribution for subject i with















exp{β ′RZiR + wi}
Q∑
q=1
rqI(bq−1 ≤ t < bq)dt
 . (3.4)
Finally, we assume a Poisson regression model for the marks as follows,
log[E{Gi(t)|dN∗Ri (t) = 1, ZiG(t), wi}] = β
′
GZiG(t) + wi, (3.5)
where ZiG = ZiG(0), and Zi(t) is comprised of elements of Zi(0) and parametric
functions of t. With respect to the mark distribution, the likelihood contribution for
the ith subject equals
LGi = exp{Gi(t)(β
′
GZiG(t) + wi)} exp{− exp{β
′
GZiG(t) + wi}}. (3.6)
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when the integral is over the support of wi; or,
Li =
∫

















exp{β ′DZiD + wi}
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exp{β ′RZiR + wi}
Q∑
q=1




GZiG(t) + wi)− exp{β
′
GZiG(t) + wi}. (3.11)
3.2.3 Proposed estimation methods
Several approaches have been adopted to estimate frailty models. Nielsen et al.
(1992) adopted an EM algorithm by treating the frailties as unobserved quantities or
missing values. However, the EM algorithm tends to converge slowly, and standard
errors of the estimates can not be obtained directly. Another approach is the Penalized
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Partial Likelihood (PPL), proposed by McGilchrist et al. (1991). The PPL algorithm
is fast, but no standard error estimate of the frailty variance is given. Since our
proposed method would involve evaluating complex integrals with joint frailties, the
PPL method is not practical in our setting. To use the EM algorithm, conditional
expectations of the random effects given the observed data need to be calculated and
usually they do not have closed forms. In our setting, under the joint frailty models
given above, the conditional expectations of the normal frailty do not have a closed
form. Markov chain Monte Carlo (MCMC) methods (e.g., Metropolis-Hastings) could
be adopted as in Liu, Wolfe and Huang (2004), but tend to be very computational
expensive. Other options for fitting frailty models include Gaussian Quadrature,
Laplace approximation (Tierney and Kadane, 1986) and the partial quasi-likelihood
developed by Breslow and Clayton (1993). Since it is computationally fast and easy
to implement using standard statistical software, we will use Gaussian Quadrature
for our estimation.
Gaussian quadrature is well suited to numerically evaluate integrals against prob-






where p(x) is the probability density function and f(x) is a function of interest. Let
sj be the quadrature weights and xj the integration points. The Gaussian quadrature
chooses integration points in areas of high density.
For example, equation (4.8) can be approximated by weighted averages of U pre-
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GZiG(t) + su)− exp{β̂
′
GZiG(t) + su}. (3.16)
The software used in our study is SAS (version 9.2). A NLMIXED procedure
is used to carry out the intergral approximation and estimation. PROC NLMIXED
selects the number of quadrature points adaptively by evaluating the log-likelihood
function at the starting values of the parameters until two successive evaluations
have a relative difference less than the value of the pre-defined tolerance number.
The quadrature weights then will be determined based on the number of quadrature
points. An empirical Bayes estimate of the random effect wi, ŵi, is further computed
such that the negative of the log-likelihood function is minimized based on the current
vector of parameters. Then different optimizations techinques can be utilized to get
an estimate of the parameter estimates (i.e., Dual quasi-newton, Newton-Raphson).
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3.3 Simulation Study
To study the finite sample properties of the proposed estimator, we first assume
frailty wi to be normally distributed with mean 0 and variance σ
2, with σ2=0.01,
0.0625 or 0.25 to examine the scenarios where there is relatively low correlation,
moderate correlation and high correlation, respectively. The terminating event was
generated from dΛi(t) = dΛ(t) exp{β
′
DZi + wi}, a proportional hazards model where
Zi = (Zi1, Zi2, Zi3)




k=1 λkI(ak−1 ≤ t < ak), where λ1 = 0.06, λ2 = 0.03, a0 = 0, a1 = 10
and a2 = max{Xi}. We let Zi1 ∼ Bernoulli(0.5), with Zi2 generated through the
model P (Zi2 = 1|Zi1)=expit{h1Zi1} and P (Zi3 = 1|Zi1, Zi2)=expit{h2Zi1 + h3Zi2},
where (h1, h2, h3)
′ = (1, 1, 1)′ and expit(h)=exp{h}[1 + exp{h}]−1. We generated
recurrent events from the model dRi(t) = dR(t) exp{β
′
RZi + wi} by generating gap
times between successive events as: Ti,k+1 = Ti,k − log(Ui,k)[dR(t) exp{β′RZi + wi}]−1
for k = 1, . . . , 50, where each of the Ui,k variates followed a Unif(0,1) distribution.
For simplicity, we let dR(t) =
∑2
q=1 rqI(bq−1 ≤ t < bq), with r0 = r1 = 0.20, b0 =
0, b1=median{Tik} and b2 = max{Tik} so that the piecewise constant assumption is
still satisfied. The regression parameter was set to βR = (0.5, 0.3, 0.3)
′. The model for
the marks was as follows: log[E{Gi(t)|dN∗Ri (t) = 1, Zi(t), wi}] = β′GZi +wi + 2t, with
βG = (0.5, 0.3, 0.3)
′. Censoring times were generated from a Unif(0,30) which resulted
in about 30% of censoring. The average observed number of recurrent events is about
three per subject. We used five quadrature points in our estimations. Sample sizes
were set at n = 2000 and 2000 replicates were generated for each data configuration.
Table 3.1 provides performance of the parameters under very low correlation
(σ2 = 0.01) among the terminating events, recurrent events and marks. Since the cor-
relation is very small (close to independence), estimation with or without considering
the frailty wi, both achieved fairly good performance in terms of bias and coverage
probability. For all parameters, the estimated values are very close to the true values.
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The average asymptotic standard errors (ASE) agree well with the empirical standard
deviations (ESD) and, correspondingly, the empirical coverage probabilities (CP) are
close to the nominal value of 0.95.
In Table 3.2, the correlation among the terminating events, recurrent events and
marks was increased to be moderately large (σ2 = 0.0625). In this setting, not con-
sidering the correlation resulted in increased bias and worse coverage. If we consider
the frailty effect, the biases are negligible and the ASEs agree well with the ESDs
with CPs generally being close to the nominal value of 0.95.
Last, we examine the results from Table 3.3 where correlation among the termi-
nating events, recurrent events and marks was quite large (σ2 = 0.25). The variance
contributed by the frailty are over half of the total variance explained. Under this
scenario, the estimation procedure including the frailty still outperforms the estima-
tion procedure without frailty by a large extent. We can see from Table 3.3 that
without considering the frailty resulted in highly elevated biases for most of the pa-
rameters and the variances of the parameter estimators are underestimated, yielding
much lower CPs.
3.4 Application
We applied our methods to data obtained the previously-described CANUSA Peri-
toneal Dialysis Study. In this analysis, all patients commencing continuous PD be-
tween September 1, 1990 and December 31, 1992 were eligible for the study. De-
mographic data recorded at enrollment included age, sex, race, functional status
(according to the Karnofsky score), underlying renal disease, insulin-dependent di-
abetes mellitus (IDDM), and history of cardiovascular disease (CVD). Estimates of
nutritional status included subjective global assessment (SGA), and percentage of
lean body mass (PCTLBM). Adequacy of dialysis was estimated by measurement
of total weekly Kt/V for urea, total weekly creatinine clearance (CCr), and serum
38
beta-2-microglobulin(β2M). Death served as the terminating event, while the recur-
rent event was hospitalization. Length of stay (number of days hospitalized) served
as the mark for each hospital visit.
A total of n = 679 patients were enrolled. There were many more males (393)
than females (286) enrolled in the study. The mean age was 54, with a range of 18
to 82 years. Follow-up was terminated December 31, 1993. There were 90 deaths,
and the average number of days hospitalized across all patients was 7.8 days per
patient. Adjustment covariates included serum albumin (SALB), normalized pro-
tein catabolic rate (NPCR), subjective global assessment (SGA), percent lean body
mass (PCTLBM), Kt/V, total weekly creatinine clearance (CCr), gender, race, age,
Karnofsky score, underlying renal disease and cardiovascular disease (CVD).
As evident from Table 3.4, the covariates that are significant for the proportional
hazards model include SALB, percent lean body mass and Age. A 1g/L increase
in serum albumin concentration is associated with 11% decrease in the death haz-
ard, adjusting for other covariates and conditional on the frailty. A 1% increase in
lean body mass is associated with a 5% decrease in the hazard adjusting for other
covariates. One year increase in age will result in 2% increase in hazard.
Factors that are significant predictors of the recurrent event rate include serum
albumin, percentage lean body mass, Karnofsky score and Age. For example, a 1g/L
increase in serum albumin concentration is associated with 6% decrease in hospital-
ization rate, adjusting for other variables. Age is the only significant variable in the
Poisson regression model. Overall, serum albumin and percent lean body mass show
up significant in two of three models where age is significant for all three models.
The heterogeneity effect are estimated through the variance of the frailty term. It
appears to be highly significant(p-value<0.001). This shows much variation among
the study subjects. The bottom half of Table 3.4 provides a comparison of parameter
estimates based on a model which ignores the heterogeneity among the subjects. We
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notice various degrees of bias in the parameter estimates, along with the changes in the
significance levels for some of the clinical and demographic factors in the proportional
hazards model, proportional rates model or the Poisson regression model.
3.5 Discussion
In this Chapter, we developed joint modelling methods to estimate the importance
of certain parameters of interest. This is well suited to our hierarchical data setting
where we have a sequence of recurrent events that could be stop by a terminating
event. The marks that characterize each recurrent event are dependent upon the exis-
tence of each recurrent event. We specify separate models for each process (recurrent
event process, terminating event process and mark process). The frailty term which
is subject specific captures the dependence structure among the above three processes
and serves as the bridge for our joint estimation. We assume a piecewise constant
proportional hazards models for the terminating event while we assume a piecewise
constant proportional rates model for the recurrent event rate given survival. We
further assume a Poission regression type of model for the marks. One of our main
contributions to the existing literature is the introduction of the marks. Here, we
restrict the marks to be non-negative. In the conventional recurrent event literature,
many papers focus on the recurrent event process itself (Cook and Lawless, 1997;
Ghosh and Lin, 2000, 2002; Schaubel and Zhang, 2010). Their models essentially
count the number of recurrent event occurrence, each event occurrence being binary
(either 0 or 1). We built upon the notion that although marks are related to each
recurrent event, they are not necessarily restricted to be binary. The marks can have
their own processes depending upon the behavior of the marks. In other words, if we
restrict the marks all to be identity, our models could be reduced to methods that
only considering the recurrent event processes.
In this Chapter, we demonstrated the importance of capturing the heterogeneity
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effect in modelling consideration. For example, a study population maybe not be
homogeneous (some individuals will have higher hazards of death or recurrence of
certain disease compared to others). In addition, it might be hard to measure all the
factors related to the disease due to resources or other reasons. This makes models
incorporating the frailty effect more reasonable. Our results show that when hetero-
geneity is present, building models without considering the effect of heterogeneity will
cause different degree of biases depending on the scale of the heterogeneity effect.
Methods developed in this Chapter involve building parametric models for each
of the underlying processes (i.e., recurrent event, terminating event, mark). In each
of the processes, the frailty term was built in to represent the heterogeneity effect.
They are assumed to be shared among all three processes. This assumption could be
relaxed by introducing more than one frailty term. For example, we could quantify the
dependence between the recurrent event process and the mark process by including
one frailty term while using another frailty term for the mark process and terminating
event process. The trade-off of introducing more than one frailty term is the added
computation complexity since we need to estimated more parameters. Another point
to mention is that the distribution of the the frailty term is assumed to be normal
in the development of our models. Other distributions for the frailty term are also
possible in building the models. (e.g., Gamma distribution).
We utilized Gaussian quadrature techniques in estimating the parameters of in-
terest. The advantage of using Gaussian quadrature is the computation speed and
relative accuracy. In order to use Gaussian quadrature, we would need to fully spec-
ify the likelihood function for the models described in this Chapter. Therefore, the
models need to be fully parameterized. We typically do not know the true underly-
ing models. Although, efficiency gains would result if the models being specified are
accurate, substantial bias could arise if we have model misspecification.
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Table 3.1: Simulation Results: Performance of the proposed parameter
estimators under small heterogeneity
Parameters Bias ESD ASE CP BIAS∗ ESD∗ ASE∗ CP ∗
r1 0.000 0.008 0.008 0.95 0.001 0.008 0.008 0.95
r2 0.000 0.007 0.007 0.95 0.000 0.007 0.007 0.95
λ1 0.000 0.004 0.004 0.96 0.000 0.004 0.004 0.96
λ2 0.000 0.003 0.003 0.95 0.000 0.003 0.003 0.95
βG1 -0.002 0.022 0.022 0.94 -0.003 0.022 0.021 0.93
βG2 0.006 0.021 0.022 0.96 0.006 0.021 0.021 0.94
βG3 -0.002 0.022 0.022 0.96 0.004 0.022 0.021 0.93
βD1 0.001 0.057 0.058 0.95 0.000 0.057 0.058 0.95
βD2 0.005 0.064 0.061 0.94 0.003 0.064 0.060 0.94
βD3 -0.004 0.068 0.070 0.93 -0.005 0.068 0.069 0.93
βR1 -0.002 0.029 0.031 0.95 -0.005 0.029 0.030 0.94
βR2 0.003 0.031 0.032 0.96 0.001 0.030 0.031 0.96
βR3 -0.002 0.035 0.036 0.97 -0.003 0.035 0.036 0.95
σ2 0.000 0.004 0.004 0.92 - - - -
Notes: βD = (0.5, 0.3, 0.3)
′, βR = (0.5, 0.3, 0.3)
′, βG = (0.5, 0.3, 0.3)
′,λ1 = 0.06,
λ2 = 0.03, r1 = 0.2, r2 = 0.2, σ
2 = 0.01. Number of repetitions: 2000. Number of
subjects: n = 2000. *Estimation assuming no correlation among terminating events,
recurrent events and marks.
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Table 3.2: Simulation Results: Performance of the proposed parameter
estimators under moderate heterogeneity
Parameters Bias ESD ASE CP BIAS∗ ESD∗ ASE∗ CP ∗
r1 0.000 0.008 0.008 0.96 0.008 0.008 0.008 0.82
r2 0.000 0.007 0.008 0.94 -0.004 0.008 0.007 0.89
λ1 0.000 0.004 0.004 0.96 0.001 0.004 0.004 0.95
λ2 0.000 0.003 0.003 0.95 -0.001 0.003 0.003 0.93
βG1 -0.004 0.024 0.026 0.97 0.003 0.024 0.020 0.90
βG2 0.015 0.024 0.026 0.94 0.026 0.025 0.021 0.71
βG3 0.000 0.025 0.026 0.95 0.021 0.026 0.021 0.77
βD1 -0.006 0.060 0.059 0.94 -0.020 0.059 0.058 0.94
βD2 0.015 0.064 0.062 0.95 0.006 0.062 0.061 0.94
βD3 -0.009 0.068 0.071 0.95 -0.016 0.065 0.069 0.95
βR1 -0.008 0.031 0.034 0.96 -0.024 0.031 0.030 0.86
βR2 0.016 0.031 0.035 0.95 0.006 0.031 0.031 0.96
βR3 -0.007 0.037 0.040 0.96 -0.016 0.038 0.036 0.90
σ2 -0.001 0.006 0.006 0.94 - - - -
Notes: βD = (0.5, 0.3, 0.3)
′, βR = (0.5, 0.3, 0.3)
′, βG = (0.5, 0.3, 0.3)
′,λ1 = 0.06,
λ2 = 0.03, r1 = 0.2, r2 = 0.2, σ
2 = 0.0625. Number of repetitions: 2000. Number of
subjects: n = 2000. *Estimation assuming no correlation among terminating events,
recurrent events and marks.
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Table 3.3: Simulation Results: Performance of the proposed parameter
estimators under large heterogeneity
Parameters Bias ESD ASE CP BIAS∗ ESD∗ ASE∗ CP ∗
r1 0.000 0.009 0.010 0.97 0.029 0.010 0.009 0.10
r2 -0.001 0.009 0.009 0.96 -0.013 0.009 0.007 0.54
λ1 0.010 0.004 0.004 0.97 0.004 0.004 0.004 0.88
λ2 -0.001 0.003 0.003 0.96 -0.004 0.002 0.003 0.61
βG1 -0.008 0.026 0.036 0.99 0.027 0.036 0.020 0.59
βG2 0.032 0.029 0.036 0.90 0.065 0.041 0.020 0.26
βG3 0.010 0.029 0.036 0.97 0.100 0.039 0.020 0.07
βD1 -0.013 0.064 0.064 0.95 -0.060 0.058 0.058 0.84
βD2 0.029 0.065 0.067 0.93 0.000 0.061 0.061 0.94
βD3 -0.008 0.069 0.076 0.97 -0.032 0.064 0.069 0.94
βR1 -0.014 0.036 0.041 0.98 -0.070 0.037 0.030 0.38
βR2 0.032 0.035 0.043 0.93 -0.002 0.037 0.032 0.91
βR3 -0.012 0.043 0.048 0.96 -0.039 0.045 0.036 0.75
σ2 -0.010 0.012 0.013 0.85 - - - -
Notes: βD = (0.5, 0.3, 0.3)
′, βR = (0.5, 0.3, 0.3)
′, βG = (0.5, 0.3, 0.3)
′,λ1 = 0.06,
λ2 = 0.03, r1 = 0.2, r2 = 0.2, σ
2 = 0.25. Number of repetitions: 2000. Number of
subjects: n = 2000. *Estimation assuming no correlation among terminating events,
recurrent events and marks.
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Table 3.4: Analysis of CANUSA study: Heterogeneity effect and parameter esti-
mates under proportional hazards model, porpotional rates model and
the Poisson regression model
dΛi(t) dRi(t) Gi(t)
Variable β̂D SE p β̂R SE p β̂G SE p
Frailty(Yes)
SALB -0.112 0.024 <0.001 -0.057 0.011 <0.001 -0.004 0.010 0.719
NPCR -0.008 0.586 0.989 -0.007 0.276 0.981 0.049 0.241 0.840
SGA -0.005 0.087 0.952 -0.113 0.041 0.006 -0.013 0.036 0.729
PCTLBM -0.053 0.013 <0.001 -0.003 0.005 <0.001 -0.009 0.005 0.057
KTV -0.030 0.219 0.891 -0.074 0.111 0.505 0.038 0.096 0.691
CCR -0.003 0.006 0.669 0.002 0.003 0.509 0.001 0.002 0.926
CANADA 0.010 0.345 0.976 -0.009 0.164 0.955 -0.015 0.142 0.916
GENDER -0.020 0.262 0.938 -0.044 0.126 0.725 0.091 0.110 0.406
RACE -0.031 0.144 0.829 -0.028 0.070 0.686 0.076 0.062 0.220
AGE 0.021 0.009 0.027 -0.015 0.004 <0.001 0.033 0.003 <0.001
KARNOF -0.002 0.009 0.866 -0.019 0.005 <0.001 -0.003 0.004 0.511
PRD 0.002 0.074 0.982 0.026 0.037 0.480 -0.048 0.032 0.130
CVD 0.041 0.261 0.876 0.006 0.128 0.965 0.089 0.011 0.425
σ̂2 1.325 0.083 <0.001 - - - - - -
SALB -0.054 0.021 0.012 -0.047 0.005 <0.001 0.006 0.002 0.000
NPCR -0.010 0.544 0.986 -0.015 0.134 0.908 0.504 0.038 <0.001
SGA 0.008 0.077 0.922 -0.064 0.019 0.001 0.008 0.006 0.172
PCTLBM -0.040 0.013 0.002 -0.027 0.003 <0.001 -0.006 0.001 <0.001
KTV -0.047 0.198 0.814 -0.176 0.065 0.007 -0.122 0.019 <0.001
CCR -0.001 0.005 0.898 0.004 0.002 0.003 0.001 0.000 0.001
CANADA 0.012 0.310 0.973 -0.010 0.077 0.895 -0.139 0.025 <0.001
GENDER -0.026 0.232 0.911 -0.093 0.061 0.126 0.272 0.018 <0.001
RACE -0.040 0.143 0.779 -0.089 0.033 0.007 0.081 0.009 <0.001
AGE 0.020 0.009 0.035 -0.023 0.002 <0.001 0.020 0.001 <0.001
KARNOF -0.001 0.009 0.885 -0.018 0.002 <0.001 0.005 0.001 <0.001
PRD 0.010 0.066 0.886 0.008 0.017 0.642 -0.046 0.005 <0.001
CVD 0.044 0.230 0.849 0.037 0.059 0.531 0.266 0.018 <0.001
σ̂2 0 - - - - - - - -
dΛi(t): proportional hazards model;dRi(t): proportional rates model; Gi(t): Poisson regression
model.
Proposed method given in the top frame; parameter estimates in the bottom frame are based on
a model with no frailty (σ2 ≡ 0).
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CHAPTER IV
Comparison of marginal means through inverse
weighting methods
4.1 Introduction
There have been many methods developed for analysing recurrent event data in
terms of various marginal means or rates models, largely due to the interpretation of
the parameters and the fact that no particular dependency through event history need
be assumed; e.g., Pepe and Cai, 1993; Lawless and Nadeau, 1995; Lin, Wei, Yang and
Ying, 2000; Cai and Schaubel, 2004. Pepe and Cai (1993) developed partly marginal
regression models that accommodate time dependent covariates. Later, Lawless and
Nadeau (1995) presented robust semi-parametric techniques for estimating the cu-
mulative mean function in discrete time. Lin et al. (2000) extended the approach
of Lawless and Nadeau (1995) to continuous time and rigorously derived the asymp-
totic properties using empirical processes. Cai and Schaubel (2004) further proposed
semi-parametric marginal means/rates model by allowing for more than one type of
recurrent event. They also developed asymptotic properties for the parameter esti-
mators. Investigators are often interested in estimating differences between groups
(e.g., treatment versus control), and one approach is to make comparisons through
the marginal means.
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In this Chapter, we are interested in descriptive measures (i.e., “marks”) that
are associated with each recurrent event (e.g., repeated hospital admissions, epileptic
seizures). Examples include entities such as the cost billed for each hospital visit,
or the length of stay. In the recurrent event data setting, few methods have been
proposed to analyze such type of data. One such method is that of Cai, Zeng and Pan
(2010), which proposed a proportional means model for the marks, contingent upon
the recurrent event occurrences, along with a marginal rate model for the recurrent
event. Since in clinical trials or animal studies, study subjects may experience a
terminating event (e.g., death), it is therefore necessary to acknowledge the fact that
the recurrent event process could potentially be stopped permanently. The methods
of Cai et al. (2010) would not apply to settings involving a terminating event.
A number of methods have been developed where both the recurrent event and
terminating event are present. For example, Cook and Lawless (1997) developed
models for the conditional recurrent event rate given survival. Ghosh and Lin (2000)
proposed non-parametric inference procedures for the mean function, and later de-
veloped semi-parametric models for the marginal mean number of events (Ghosh and
Lin, 2002). In such models, death is treated as a terminating event that prevents fur-
ther recurrent event occurrence. Huang and Wang (2004) developed joint modelling
techniques where a latent frailty variable is used to associate the recurrent event rate
and terminating event hazard. The general data structure considered in this Chapter
involves a sequence of recurrent events that could potentially be stopped by a termi-
nating event. A mark is associated with each recurrent event, with marks only being
observed when each recurrent event occurs.
The motivating example for our proposed methods is the Canada-USA (CANUSA)
Peritoneal Dialysis (PD) Study (Canada-USA (CANUSA) Peritoneal Dialysis Study
Group, 1996; Churchill 1998; Ye, Kalbfleisch and Schaubel, 2007). In this study,
the sample consisted of PD patients starting dialysis in either Canada or USA. Such
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patients experience repeated hospitalizations over the course of the study period.
Whenever each hospitalization occurs, the number of days hospitalized are recorded.
Demographic and some clinical information is collected at start of follow-up. Patients
are removed from the study if either death or transplant occurs.
Of interest in Chapter IV is the integrated mark process, viewed as a function
of time; as was the case in Chapter II. For example, in the motivating example
(CANUSA Study), the recurrent event is hospital admission, the terminating event
is death, and the mark is length of stay (measured in days). As a result, cumulative
mark equals the total days hospitalized. The proposed methods take into account of
treatment imbalance and censoring by incorporating Inverse Probability of Treatment
Weighting (IPTW; Robins et al. 2000; Hernan et al. 2000; Anstrom and Tsiatis
2001) and Inverse Probability of Censoring Weighting (IPCW; Robins and Rotnitzky
1992; Robins 1993), respectively. We avoid building models for the recurrent event
rate, terminating hazard and mark. The advantage of this less parametric approach
is that we do not require models for each process to be correct (e.g., proportional
hazards model, proportional rates model) in order to achieve consistent estimates of
the marginal mean.
In Section 4.2, we introduce the proposed estimator and estimating methods.
Asymptotic properties are given in Section 4.3, with proofs provided in the Appendix.
Simulation studies are conducted in Section 4.4. An application of our proposed
methods is given in Section 4.5, followed by discussion in Section 4.6.
4.2 Proposed Estimation Methods
4.2.1 Notation and Setup
We first establish the required notation. Let Di denote the time of the termi-
nating event for subject i, while Ci is the censoring time for subject i. We let
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Xi = min(Ci, Di) and let Yi(t) = I(Xi ≥ t) be the at-risk indicator. We let the
true terminating event counting process be represented by N∗Di (t) = I(Di ≤ t) and
we let N∗Ri (t) equal the total number of recurrent events for subject i up to time
t. The observed terminating event counting process and recurrent event process are
NDi (t) = I(Di ≤ t,Di < Ci) and NRi (t) = N∗Ri (t ∧ Xi), respectively. Notice that
recurrent events do not occur after death. We define Gi(t) as the mark for subject
i at time t. It is assumed that marks only occur at time of a recurrent event. In
addition, subjects are divided into groups (e.g., by treatment type, gender, diagnosis;
whatever is of chief interest to the investigator) and Ai is used to denote group for
subject i. For ease of presentation, we consider the case where Ai is binary (Ai = 0, 1),
although the proposed methods can easily accommodate more than two groups. We
then set up the group indicator Aij = I(Ai = j). Each subject is characterized by
a vector of possibly time dependent covariates, Zi(t). Typically, one would want
to make the j = 0 and j = 1 groups comparable at time 0 (balance the baseline
covariate distribution); would generally not want to adjust for events after t = 0.
We set the baseline value of the covariate vector to Zi ≡ Zi(0). Finally, we define
Fi(t) = {Ni(s), Gi(s), Zi(s); s ∈ [0, t)} as the recurrent event, mark and covariate
history up to (but not including) time t.







with mean µij(t), defined as
µij(t) = E[B
∗
i (t)|Zi, Ai = j].
That is, µij(t) represents the mean of B
∗
i (t) for a subject with covariate Zi, under
49
the hypothetical scenario where subject i is a member of group j. To contrast group-
specific means, we first define µj(t) as the cumulative mean for group j, averaging
across the marginal distribution of Zi. That is,
µj(t) ≡ E[µij(t)] = E[E[B∗i (t)|Ai = j, Zi]], (4.1)
for j = 0, 1, where the inner expectation conditions on Zi and Ai = j, irrespective of
the group to which subject i actually belongs (i.e., under the hypothetical scenario
where, possibly contrary to fact that, Ai = j), and the outer expectation is taken
with respect to the marginal distribution of Zi. This way, even if the Zi distributions
are quite different across groups, µ0(t) and µ1(t) are comparable, in the sense that
each is averaged with respect to the same covariate distribution. The quantity of
chief interest is the difference in cumulative means between the two groups, which is
expressed as
δ(t) = µ1(t)− µ0(t). (4.2)
The goal here is to estimate δ(t), methods for which are proposed in the next subsec-
tion.
4.2.2 Estimation
We develop semi-parametric procedures to estimate treatment-specific means.
The proposed methods assume no functional form with respect to the relationship
between the treatment-specific mean functions. If the treatment were randomized, a





i=1 I(Ai = j)Gij(u)dN
∗
ij(u)∑n
i=1 I(Ai = j)
. (4.3)
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In observational studies, treatment is rarely randomized and, in the absence of ran-
domization, the above estimator would be generally biased due to confounding. In
addition to the aforementioned obstacle, censoring times are unknown for subjects
observed to die. In order to tackle the above two complexities, we propose an inverse-
weighted estimator. IPTW is utilized to account for the treatment imbalance, while
IPCW is utilized to account for censoring.
4.2.3 Proposed Estimator: Inverse Weighting
The idea of using IPTW is to essentially create treatment-specific pseudo-populations
with the same adjustment covariate distribution. An IPTW based nonparametric es-
timator of the mean of treatment group j has the interpretation of mean number of
recurrent events which would result if the whole population had received treatment
j. In order to derive the IPTW weight, we assume a logistic model for Ai given Zi,




where i = 1 . . . n and j = 0, 1. Under maximum likelihood, we can get an estimate of






Correspondingly, the purpose of using a IPCW weight is to replace the unobserved
quantity, in this case Gi(t)dN
∗R
i (t), by an observed quantity which has the same





P{t ≤ Ci < t+ dt, Ci < Di|Xi ≥ t,Fi(t), Ai = j} (4.6)
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We set up the time-dependent covariate ZCi (t) to satisfy λ
C
ij{t|ZCi (t), Ai = j} =
λCij{t|Fi(t), Ai = j}. That is, ZCi (t) consists of time-dependent covariates, ZCi (t), plus
components of the event and/or mark history that predict censoring. We assume the








and let ΛCij(t) =
∫ t
0
λCij(s)ds. Then the IPCW weight w
C
ij(t) can be estimated by the
following,
ŵCij(t) = exp{Λ̂Cij(t)}, (4.8)








i (s) and π̂j(s) = n
−1∑n
i=1 AijYi(s) exp{β̂′ZCi (s)}.












which is IPTW and IPCW weighted, is a consistent estimator of µj(t). Therefore,
the differences in cumulative means between the two groups can then be consistently
estimated by,
δ̂(t) = µ̂1(t)− µ̂0(t). (4.10)
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4.3 Asymptotic Properties
In this section, we summarize the essential asymptotic behavior of the proposed
estimators by first listing the necessary conditions, for i = 1, . . . , n and j= 0, 1.
(a) {NRi (.), Xi, Zi(.), Ai, Gi(.)} are independent and identically distributed
(b) Pr(Yi(t) = 1) > 0 for all t ∈ [0, τ ], where τ is a pre-specified constant
(c) NRi (τ) <∞ and ΛC0 (τ) <∞
(d) 0 < Pr(Ai = j|Zi) < 1 for j = 0, 1.
(e) Covariates Zil(t) are bounded almost surely, where t ∈ [0, τ ] and Zil(t) is the
lth element of Zi(t)
(f) Positive-definiteness of the matrices, ACj (βC) and I(θ), where
ACj (βC) = E
 τ∫
0
{ZCi (t)− z̄(t; βC)}⊗2Yi(t)λCij(t)dt









j (t; βC) = E[AijYi(t)Zi(t)
⊗d exp{β ′CZi}], d = 0, 1, 2.
I(θ) = E[Z⊗2i (1− pij(θ))pij(θ)]
Now, we summarize the asymptotic properties from the proposed procedures.
Proofs of the theorems are provided in the Appendix.
Theorem IV.1. Under the above regularity conditions, µ̂j is a uniformly consistent
estimator of µj. That is, µ̂j(t) converges to µj(t) almost surely for j=0,1 and t
∈ (0, τ ]. In addition, n1/2{µ̂j(t) − µj(t)} converges weakly to a zero-mean Gaussian
























































Aij{ZCi (t)− z̄(t; βC)}dMCij (t; βC)











dMCij (s) = Aij{dNCi (s)− Yi(s)dΛCij(s)}.
The proof of the above theorem involves the Weak Law of Large Numbers (WLLN),
series of Tayor expansions, Central Limit Theorem (CLT) and various results from
empirical processes (Pollard, 1990; van der Vaart and Wellner 1996).
Theorem IV.2. Under the above regularity conditions, δ̂(t) is a uniformly consistent
estimator of δ(t). That is, δ̂(t) converges to δ(t) almost surely for j=0,1 and t ∈ (0, τ ].
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Furthermore, n1/2{δ̂(t)−δ(t)} converges weakly to a zero-mean Gaussian process with
covariance function ∆(s, t) = E[{ψi1(s)− ψi0(s)}{ψi1(t)− ψi0(t)}].
It follows from Theorem 1 that n1/2{µ̂1(t)− µ̂0(t)} is asymptotically equivalent to
n−1/2
∑n
i=1{ψi1(t) − ψi0(t)}, a scaled sum of zero-mean Normal variates. For fixed
(s, t), convergence follows from the MCLT. Tightness can be demonstrated using
results from empirical processes theory, which completes the process aspect of the
proof.
4.4 Simulation Study
We evaluated the finite-sample properties of the proposed estimator through sim-
ulation. The terminating event was generated from λij(t) = λ0j exp{β
′
DZi}, a propor-
tional hazards model where Zi = (Zi1, Zi2, Zi3)
′. The Cox regression parameter was
set to βD = (0.5, 0.3, 0.3)
′, with λ0j=0.03 or 0.06. We let Zi1 ∼ Bernoulli(0.5), with
Zi2 generated through the model P (Zi2 = 1|Zi1)=expit{h1Zi1}, P (Zi3 = 1|Zi1, Zi2)=
expit{h2Zi1 + h3Zi2} and P (Ai = 1|Zi1, Zi2, Zi3)=expit{h2Zi1 + h3Zi2 + h4Zi3} where
(h1, h2, h3, h4)
′ = (1, 1, 1, 1)′ and with expit(h)=exp{h}[1 + exp{h}]−1. We gener-
ated recurrent events from the model rij(t) = Qir0j exp{β
′
RZi} by generating gap
times between successive events as: Ti,k+1 = Ti,k − Qi log(Ui,k)[r0j exp{β′RZi}]−1
for k = 1, . . . , 50, where each of the Ui,k variates followed a Unif(0,1) distribu-
tion. The frailty, Qi, could be considered an unmeasured predictor that is shared
by all recurrent event times for the same subject. We let Qi ∼ Gamma(θ) where
θ= 0.5 or 0.25 and represents Var(Qi); note that E(Qi) = 1. We set r0j= 0.25
or 0.20, with the regression parameter set to βR = (0.5, 0.3, 0.3)
′. The model for
the marks was as follows: gi(t) = βG0 + βG1t + βG2Zi1 + βG3Zi2 + βG4Zi3, with
(βG0 , βG1 , βG2 , βG3 , βG4)






−)} and truncated at 60, which resulted in
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about 30% to 40% of censoring for different simulation configurations. In the above
model, λC0j = 0.03, βC = (0.2, 0.2, 0.2)
′ and Ni(t
−) = Ni(t) − dNi(t), the number of
recurrent event up to (but not including) time t. The average observed number of
recurrent events ranged from 2 to 4 per subject. Cumulative means were estimated at
t = 3, 6, 9, 12, in order to give comparisons for early, middle and late follow up times.
Sample sizes were set at n = 400 and 500 replicates were generated per configuration.
Table 4.1 provides results for the population average cumulative mean estimator
for the various data configurations examined. For all data configurations, the esti-
mated cumulative means are very close to the true values. The average asymptotic
standard errors (ASE) agree well with the empirical standard deviations (ESD) and,
correspondingly, the empirical coverage probabilities (CP) are close to the nominal
value of 0.95.
In Table 4.2, we evaluated the proposed treatment effect estimator, δ̂(t) = µ̂1(t)−
µ̂0(t). The biases at different follow-up times are negligible compared to the true
values. The ASEs also agree well with the ESDs, with the CP being generally quite
close to the nominal value of 0.95.
To compare relative efficiencies to estimator proposed in Chapter II, we generated
data under the same settings as those described in Chapter II. Table 4.3 provides
results for µ̂1(t) for the various data configurations examined. For all data configura-
tions, the estimated cumulative means are very close to the true values. Compared
with the estimators presented in Table 2.1, we can see that we achieve substantial
efficiency gains by utilizing the inverse weighted estimator. In Table 4.4, we eval-
uated the proposed treatment effect estimator, δ̂(t) = µ̂1(t) − µ̂0(t). The biases at
different follow-up times are negligible compared to the true values. Note that for the
simulation presented in Table 4.3 and Table 4.4, the recurrent event process does not




Data were obtained from the Canada-USA (CANUSA) peritoneal dialysis (PD)
study. More than three years of data were collected, including demographic, nutri-
tional status, adequacy of dialysis. The final study population consists of n = 679
peritoneal dialysis patients from either US (577 patients) or Canada (102 patients).
During the follow-up period, these PD patients may experience repeated hospitaliza-
tion, death, transplant or loss of follow-up.
In our analysis, repeated hospitalizations were treated as recurrent event of interest
while death were considered as the terminating event. The number of days hospital-
ized associated with each hospital admission was considered the mark. Chief interest
in our analysis is to compare the marginal mean number of total days hospitalized
between the PD patients from US and Canada. The CANUSA data being handled
in this application has a hierarchical type of structure: patients are hospitalized con-
ditioning on being alive up to their hospitalization visit; number of days hospitalized
being observed are conditioned on each occurrence of hospital visit. In addition, we
treat transplant or loss of follow-up as censoring event. The adjustment covariate
included serum albumin (SALB), subjective global assessment (SGA), percent lean
body mass (PCTLBM), Kt/V, CCR, gender, race, age, cardiovascular disease (CVD)
and the event history.
The results given were based on the inverse weighting method where inverse prob-
ability of censoring weighting and inverse probability of treatment weighting were
both considered. We first fitted a logistic regression model and a proportional haz-
ards model to detect any significant covariates of interests. The logistic regression
model, pij(θ0), models the probability of being Canadian, given the covariates. The
proportional hazards model, λCij(t), was stratified by country. As shown in Table 4.5,
SGA, PCTLBM, KTV, CCR, gender, race and age are all significant or borderline
significant for the logistic regression model; while SALB, PCTLBM, age, CVD and
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event history are significant predictors for the proportional hazards model. For ex-
ample, a 1 % increase in lean body mass is associated with 4% decrease in the odds of
being Canadian, adjusting for other covariates. Those having a history of CVD will
have 2.11 times higher hazards of censoring compared with those without a history
of CVD, adjusting for other covariates. Similarly, each additional hospital visit is
associated with an 8% times higher hazard of censoring, adjusting for other covari-
ates. Generally, higher percent of lean body mass, fewer hospitalizations, absence of
cardio-vascular disease history and increase in SALB are each associated with lower
risk of censoring.
Figure 4.1 presents the estimated cumulative mean number of days hospitalized
for American and Canadian patients over a two year period. From the figure, we
can notice that overall the estimated mean number of days hospitalized are similar
between the two groups, with the solid line being close to the dashed line. Canadian
PD patients have a slightly higher number of days hospitalized compared with the
American patients throughout the two year period.
Figure 4.2 gave the mean difference estimator between the American and Cana-
dian PD patients with 95 % pointwise confidence intervals plotted. As is evident from
Figure 4.2, the mean difference estimator is very close to the reference (δ̂(t) = 0) over
time. Throughout the two year period, the difference was slightly above zero. Cor-
respondingly, we computed the estimated mean difference and associated asymptotic
standard error at every half year interval as shown in Table 4.6. We notice that the
estimated mean difference are close to zero and the differences are all non-significant.
This means that American PD patients compared with their Canadian counterparts




The method developed in this Chapter combines an Inverse Probability of Treat-
ment Weighting (IPTW) and Inverse Probability of Censoring Weighting (IPCW).
In the development of IPTW, treatment assignment is dependent upon the baseline
covariate distribution, such that treatment imbalance exists between any two com-
parison groups. For ease of interpretation, we demonstrated the performance under
two comparison groups, but the proposed methods can easily be extended to settings
where there exist more than two groups. In the development of IPCW, we allowed the
censoring mechanism to depend on the covariate distribution, and the event history.
Although we have strong dependence structure, our methods still perform very well
under various simulation settings.
In this Chapter, we are mainly interested in the marginal cumulative differences
between any two comparison groups. The estimator developed in this Chapter does
not assume any underlying models for the recurrent event process, terminating event
process or the mark process. On the contrary, the estimator proposed in Chapter II
would need to allow the individual models to be specified correctly. Otherwise, we
could see biased parameter estimates that could undermine the true outcome. Even
though comparing with methods developed in Chapter II, we can see that under lim-
ited sample size, two methods achieve quite similar results. The estimator developed
in this Chapter would achieve more robust results under model misspecification.
Schaubel and Zhang (2010) also proposed methods to estimate treatment effect on
the marginal recurrent event mean via inverse weighting. Though there are similarities
to our methods, Schaubel and Zhang (2010) did not consider the existence of marks.
They used IPTW, and proposed two methods of dealing with Ci (e.g., imputing Ci
when Di < Ci; IPCW). In their IPCW model, they assume that neither covariates
nor recurrent event history predicted censoring, which is quite stringent. We made
the IPCW component richer. We did not consider an imputation approach, as it
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would seem to be difficult to carry out in the sense that more complex modelling
would need to be done than in Schaubel and Zhang (2010).
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Table 4.1: Simulation Results: Performance of Proposed Inverse Weighted Estimator
λ00, λ01 r00, r01 V (Qi) t % at risk µ1(t) Bias ESD ASE CP
0.03, 0.03 0.20, 0.25 0.5 3 77% 6.98 -0.08 1.01 0.67 0.92
6 61% 16.01 -0.29 2.32 1.53 0.93
9 47% 26.12 -0.47 3.90 2.72 0.93
12 36% 36.66 -0.71 5.78 4.22 0.94
0.03, 0.03 0.20, 0.25 0.25 3 77% 6.98 -0.10 0.74 0.62 0.93
6 61% 16.01 -0.26 1.72 1.39 0.92
9 47% 26.12 -0.31 3.02 2.43 0.93
12 36% 36.66 -0.36 4.56 3.77 0.92
0.03, 0.06 0.25, 0.25 0.5 3 70% 6.23 0.02 0.64 0.63 0.93
6 48% 12.84 0.06 1.41 1.33 0.92
9 38% 18.98 0.13 2.33 2.15 0.92
12 29% 24.38 0.25 3.44 3.06 0.91
0.03, 0.06 0.25, 0.25 0.25 3 70% 6.23 0.04 0.54 0.58 0.97
6 48% 12.84 0.05 1.18 1.19 0.95
9 38% 18.98 0.05 1.85 1.85 0.96
12 29% 24.38 0.00 2.61 2.56 0.93
0.06, 0.06 0.25, 0.20 0.5 3 70% 4.99 0.00 0.46 0.52 0.96
6 48% 10.27 0.03 1.08 1.07 0.94
9 38% 15.19 0.03 1.75 1.68 0.92
12 29% 19.50 -0.02 2.44 2.32 0.92
0.06, 0.06 0.25, 0.20 0.25 3 70% 4.99 -0.02 0.46 0.49 0.96
6 48% 10.27 -0.04 0.95 0.97 0.95
9 38% 15.19 -0.07 1.48 1.50 0.95
12 29% 19.50 -0.08 2.07 2.08 0.95
Notes: βD = (0.5, 0.3, 0.3)
′, βR = (0.5, 0.3, 0.3)
′, βG = (1, 1, 1, 1, 1.5)
′. Number of
repetitions: 500. Number of subjects: n = 400.
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Table 4.2: Simulation Results: Treatment effects of Inverse Weighted Estimator
λ00, λ01 r00, r01 V (Qi) t % at risk δ(t) Bias ESD ASE CP
0.03, 0.03 0.20, 0.25 0.5 3 77% 1.40 -0.15 1.39 1.12 0.94
6 61% 3.20 -0.35 3.18 2.54 0.93
9 47% 5.22 -0.68 5.29 4.43 0.94
12 36% 7.33 -1.09 7.99 6.77 0.94
0.03, 0.03 0.20, 0.25 0.25 3 77% 1.40 -0.19 1.11 1.05 0.94
6 61% 3.20 -0.48 2.54 2.34 0.95
9 47% 5.22 -0.57 4.39 4.00 0.95
12 36% 7.33 -0.73 6.50 5.99 0.95
0.03, 0.06 0.25, 0.25 0.5 3 70% 0.75 -0.03 1.40 1.22 0.94
6 48% 3.17 -0.15 3.11 2.71 0.92
9 38% 7.14 -0.48 5.13 4.52 0.95
12 29% 12.29 -0.74 7.74 6.77 0.94
0.03, 0.06 0.25, 0.25 0.25 3 70% 0.75 -0.02 1.18 1.13 0.95
6 48% 3.17 0.04 2.54 2.49 0.93
9 38% 7.14 0.06 4.20 4.10 0.93
12 29% 12.29 0.14 6.36 6.00 0.92
0.06, 0.06 0.25, 0.20 0.5 3 70% 1.25 0.00 1.02 1.08 0.96
6 48% 2.57 -0.06 2.26 2.24 0.96
9 38% 3.80 -0.11 3.58 3.52 0.94
12 29% 4.88 -0.23 4.96 4.82 0.95
0.06, 0.06 0.25, 0.20 0.25 3 70% 1.25 0.15 0.98 1.02 0.96
6 48% 2.57 0.36 2.01 2.07 0.95
9 38% 3.80 0.51 3.09 3.20 0.95
12 29% 4.88 0.68 4.24 4.36 0.95
.
Notes: βD = (0.5, 0.3, 0.3)
′, βR = (0.5, 0.3, 0.3)
′, βG = (1, 1, 1, 1, 1.5)
′.Number of
repetitions: 500. Number of Subjects: n = 400.
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Table 4.3: Simulation Results: Performance of Proposed Inverse Weighted Estimator
λ00, λ01 r00, r01 V (Qi) t % at risk µ1(t) Bias
∗ ESD∗ Bias† ESD† RE
0.03/0.03 0.20/0.25 0.5 3 71% 6.98 -0.06 0.57 0.04 0.77 1.82
6 53% 16.01 -0.23 1.35 0.10 1.75 1.64
9 40% 26.12 -0.50 2.25 0.27 2.92 1.61
12 29% 36.66 -0.82 3.34 0.35 4.31 1.59
0.03/0.03 0.20/0.25 0.25 3 71% 6.98 -0.03 0.48 0.04 0.56 1.37
6 53% 16.01 -0.21 1.12 0.18 1.34 1.41
9 40% 26.12 -0.36 1.96 0.02 2.26 1.28
12 29% 36.66 -0.70 2.96 0.00 3.34 1.20
0.03/0.06 0.25/0.25 0.5 3 59% 6.23 0.01 0.59 0.02 0.66 1.25
6 40% 12.84 -0.15 1.19 0.02 1.50 1.56
9 23% 18.98 -0.25 1.89 0.11 2.42 1.61
12 16% 24.38 -0.33 2.61 0.22 3.31 1.59
0.03/0.06 0.25/0.25 0.25 3 59% 6.23 -0.08 0.46 0.04 0.57 1.49
6 40% 12.84 -0.16 0.99 0.04 1.22 1.49
9 23% 18.98 -0.27 1.61 0.11 1.92 1.39
12 16% 24.38 -0.40 2.29 0.04 2.64 1.30
0.06/0.06 0.25/0.20 0.5 3 59% 4.99 0.00 0.45 0.03 0.57 1.61
6 40% 10.27 -0.04 0.94 0.13 1.18 1.59
9 23% 15.19 -0.07 1.48 0.19 1.82 1.54
12 16% 19.50 -0.13 2.03 0.20 2.47 1.49
0.06/0.06 0.25/0.20 0.25 3 59% 4.99 -0.04 0.39 0.00 0.45 1.32
6 40% 10.27 -0.11 0.86 0.05 0.98 1.28
9 23% 15.19 -0.13 1.35 0.06 1.53 1.28
12 16% 19.50 -0.19 1.88 0.10 2.09 1.23
Notes: βD = (0.5, 0.3, 0.3)
′, βR = (0.5, 0.3, 0.3)
′, βG = (1, 1, 1, 1, 1.5)
′. Number
of repetitions: 500. Number of subjects: n = 400. *: Bias and ESD of estimator
in Chapter IV. †: Bias and ESD of estimator in Chapter II. RE: relative efficiency,
compared to the Chapter II estimator.
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Table 4.4: Simulation Results: Treatment effects of Inverse Weighted Estimator
λ00, λ01 r00, r01 V (Qi) t % at risk δ(t) Bias
∗ ESD∗ Bias† ESD† RE
0.03/0.03 0.20/0.25 0.5 3 71% 1.40 0.03 0.83 0.01 0.86 1.08
6 53% 3.20 -0.12 1.84 0.07 1.88 1.04
9 40% 5.22 -0.18 3.31 0.14 3.16 0.91
12 29% 7.33 -0.18 4.89 0.07 4.79 0.96
0.03/0.03 0.20/0.25 0.25 3 71% 1.40 -0.02 0.76 0.04 0.74 0.95
6 53% 3.20 -0.01 1.61 0.04 1.62 1.01
9 40% 5.22 -0.09 2.78 -0.05 2.73 0.96
12 29% 7.33 0.01 4.18 -0.25 4.04 0.94
0.03/0.06 0.25/0.25 0.5 3 59% 0.75 0.00 0.95 -0.03 0.90 0.90
6 40% 3.17 0.05 2.07 -0.07 1.94 0.88
9 23% 7.14 0.17 3.29 -0.19 3.30 1.01
12 16% 12.29 0.13 4.67 -0.59 4.78 1.06
0.03/0.06 0.25/0.25 0.25 3 59% 0.75 0.04 0.83 -0.08 0.82 0.99
6 40% 3.17 0.01 1.74 -0.08 1.80 1.08
9 23% 7.14 -0.08 2.95 -0.16 2.97 1.02
12 16% 12.29 -0.13 4.33 -0.05 4.35 1.01
0.06/0.06 0.25/0.20 0.5 3 59% 1.25 -0.03 0.86 -0.03 0.87 1.03
6 40% 2.57 -0.09 1.77 -0.13 1.74 0.97
9 23% 3.80 -0.19 2.76 -0.06 2.76 0.99
12 16% 4.88 -0.27 3.84 0.11 3.83 0.99
0.06/0.06 0.25/0.20 0.25 3 59% 1.25 0.04 0.76 0.09 0.74 0.96
6 40% 2.57 0.03 1.62 0.16 1.59 0.97
9 23% 3.80 0.06 2.56 0.25 2.53 0.99
12 16% 4.88 0.08 3.62 0.29 3.52 0.95
Notes: βD = (0.5, 0.3, 0.3)
′, βR = (0.5, 0.3, 0.3)
′, βG = (1, 1, 1, 1, 1.5)
′. Number
of repetitions: 500. Number of subjects: n = 400. *: Bias and ESD of estimator
in Chapter IV. †: Bias and ESD of estimator in Chapter II. RE: relative efficiency,
compared to the Chapter II estimator.
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Table 4.5: Analysis of CANUSA data: Parameter estimates for logistic





Variable θ̂ p Odds Ratio β̂C p exp{β̂C}
SGA 0.34 0.00 1.41 - - -
KTV -1.37 0.00 0.25 - - -
CCR 0.02 0.01 1.02 - - -
GENDER 0.47 0.10 1.59 - - -
RACE 0.24 0.06 1.28 - - -
AGE -0.01 0.14 0.99 0.02 0.07 1.02
PCTLBM -0.04 0.00 0.96 -0.03 0.00 0.97
SALB - - - -0.05 0.02 0.95
CVD - - - 0.75 0.00 2.11
EVENT HISTORY - - - 0.07 0.04 1.08
.
Notes: pij(θ0) = P{Ai = 1|Zi}, with j = 0 for US patients and j = 1 for
Canadian patients. λCij(t): proportional hazards model for censoring p: p-value
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Table 4.6: Analysis of CANUSA data: Difference in length of hospital-
ization between American and Canadian patients over time
(Canadian minus American)
Months δ̂(t) ŜE{δ̂(t)} P-value
6 1.06 2.54 0.68
12 4.29 4.53 0.35
18 3.61 6.38 0.58
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The solid line represents American (j = 0) PD patients, and dashed line represents
Canadian (j = 1) PD patients.
Figure 4.1: Analysis of the CANUSA data: Estimated cumulative mean number of


























The solid line represents the estimated cumulative mean difference in days hospitalized
(Canadian minus American). The dashed lines represent the corresponding 95%
confidence intervals.
Figure 4.2: Analysis of the CANUSA data: point estimates and 95% confidence in-
tervals for the estimated cumulative mean difference in days hospitalized






In many biomedical and health related studies, the study subjects may experience
a sequence of recurrent events (e.g., repeated hospital admissions, multiple tumor
occurrences). Often times, there are outcome measures that describe either quanti-
tative or qualitative aspects of the recurrent event, which we define as “marks”. In
addition, the sequence of recurrent events may potentially be stopped by a terminat-
ing event (e.g., death), especially during clinical trials or epidemiologic studies. In
this dissertation, we developed three novel methodologies that take into account of
the association between the recurrent event, marks and the terminating event.
In Chapter II, we developed semi-parametric methods to contrast group-specific
means. We utilized a proportional hazards model for the terminating event hazards,
a proportional rates model for the recurrent event given survival and a generalised es-
timating equation type model for the marks given each recurrent event. The marginal
mean estimator is built from the above three component models. Our estimator takes
into account potential treatment imbalances between groups by averaging over the
marginal covariate distribution, analogous to average causal effect estimators.
Since study subjects often exhibit unmeasured heterogeneity (e.g., unequal risk of
death or different rates of disease recurrence, even after conditioning on covariates),
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we developed joint modelling techniques in Chapter III via a “frailty” term. We
assumed a piecewise constant proportional hazards model for the terminating event
hazards, a piecewise constant proportional rates model for the recurrent event rate
given survival and a Poisson regression model for the marks given hospitalization. The
variance of the frailty term quantifies the scale of the dependence among the recurrent
events, terminating event and marks. Unlike Chapter II where the parameters are
estimated separately for each of the individual models, parameters in Chapter III are
estimated simultaneously via maximum likelihood.
In Chapter IV, we propose inverse weighting methods to contrast the marginal
means. We employ an Inverse Probability of Censoring Weighting (IPCW) to account
for censoring and Inverse Probability of Treatment Weighting (IPTW) to tackle treat-
ment imbalances. The IPTW weight is built through a logistic regression model while
the IPCW weight is constructed through a proportional hazards model for censoring.
Our proposed estimator in this Chapter are considered solely non-parametric if the
two weights mentioned above are absent. This is in contrast to the proposed estimator
in Chapter II where we propose a regression model for each component process.
In summary, we developed three novel methods that accommodate the data struc-
ture of our interest. Each method addresses the problem from a different angle. There
are also pros and cons in employing each method. For example, by building separate
models for each process (as in Chapter II), ideally we can achieve efficiency gain if
the models describe the data well. On the other hand, we could achieve robust re-
sults by implementing an estimator similar to the one in Chapter IV even with model
misspecification. Heterogeneity effect is solely considered in Chapter III, which is
not modelled in either Chapter II or Chapter IV. Although we considered all three
processes (e.g., terminating event process, recurrent event process and mark process)
in Chapter II, III and IV, our proposed methods could still be implemented if we
only have two of the three processes. For example, if we only have terminating event
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process and recurrent event process, we can just treat the marks associated with each
recurrent event to be identity. Likewise, if we ignore the terminating event process,





Proofs of Theorems in Chapter II
The proof of consistency and the derivation of the large-sample distribution are
the same for µ̂1(t) and µ̂0(t), j = 0 or 1. Following the proofs for µ̂1(t) and µ̂0(t), the
consistency and distribution of δ̂(t) can be directly obtained, as is evident from the
development that follows.
Proof of Theorem II.1:
Note that µ̂j(t) = n
−1∑n
i=1 µ̂j(t; β̂D, β̂R, β̂G, Λ̂0j, R̂0j|Zi). µ̃j(t) = n−1
∑n
i=1





a.s.−−→ Λ0j(t) and R̂0j(t)
a.s.−−→ R0j(t), by Continuous
Mapping Theorem, µ̂j(t)
a.s.−−→ µ̃j(t), for all t ∈ (0, τ ]. Then applying the uniform
strong law of large numbers (USSL; Pollard, 1990), we have µ̃j(t)
a.s.−−→ µj(t).
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Proof of Theorem II.2:
We can first decompose n
1












































{µj(t; βD, βR, βG,Λ0j, R0j|Zi)− µj(t)} (A.6)
Next, we consider (A.1) to (A.6) in sequence. The first part can be expanded around



























































{ZiD − z̄(r; βD)}dΛ0j(r)gij(u|ZiG)dRij(u)]
×n
1
2 (β̂D − βD).
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Through another Taylor expansion, we have n
1
















































































−|ZiD)gij(r|ZiG){ZiR − z̄(r; βR)}dR0j(r)
n 12 (β̂R − βR).
Through another Taylor expansion, n
1



























































2 (β̂G − βG)
Through another Taylor expansion, n
1










































































































































− s(0)j (u; βD)
−1
]dMDij (u; βD)
The second term goes to zero by strong convergence, the Continuous Mapping The-

























































































































k=1 ψijk(t), completing the proof.
78
APPENDIX B
Proofs of Theorems in Chapter IV










knowledging the fact that ŵCij(s)
p−→ wCij(s) and wAij(θ̂)
p−→ wAij(θ0), then applying









i (s)] = µj(t).
n1/2{µ̂j(t)− µj(t)} = n1/2{µ̂j(t; ŵA, ŵC)− µ̂j(t;wA, ŵC)} (B.1)
+n1/2{µ̂j(t;wA, ŵC)− µ̂j(t;wA, wC)} (B.2)
+n1/2{µ̂j(t;wA, wC)− µj(t)} (B.3)




































j(t) and I(θ0) are defined in Theorem IV.1. For the second term, we can
further decompose as follows
(B.2) = n1/2{µ̂j(t;wA, ŵC(t; β̂C , Λ̂C0j))− µ̂j(t;wA, ŵC(t; βC , Λ̂C0j))} (B.4)
+n1/2{µ̂j(t;wA, ŵC(t; βC , Λ̂C0j))− µ̂j(t;wA, ŵC(t; βC ,ΛC0j))} (B.5)



























































































































E[wAij(θ0) exp{βCZi(s)}wCij(s)Gi(s)dNi(s)]n1/2{Λ̂0j(s; βC)− Λ0j(s; βC)}
In the above term,
n1/2
{

















































− s(0)j (u; βC)
−1
]dMCij (u; βC)
The second term goes to zero by the almost sure convergence, continuous mapping
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theorem and USLLN. Therefore, we have
n
1

































































k=1 ψijk(t), which is a scaled sum of independent and identically dis-
tributed zero mean random variates. By the Central Limit Theorem, n1/2{µ̂j(t) −
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